124 related articles for article (PubMed ID: 24586997)
21. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
22. Characterization of gene-environment interactions for colorectal cancer susceptibility loci.
Hutter CM; Chang-Claude J; Slattery ML; Pflugeisen BM; Lin Y; Duggan D; Nan H; Lemire M; Rangrej J; Figueiredo JC; Jiao S; Harrison TA; Liu Y; Chen LS; Stelling DL; Warnick GS; Hoffmeister M; Küry S; Fuchs CS; Giovannucci E; Hazra A; Kraft P; Hunter DJ; Gallinger S; Zanke BW; Brenner H; Frank B; Ma J; Ulrich CM; White E; Newcomb PA; Kooperberg C; LaCroix AZ; Prentice RL; Jackson RD; Schoen RE; Chanock SJ; Berndt SI; Hayes RB; Caan BJ; Potter JD; Hsu L; Bézieau S; Chan AT; Hudson TJ; Peters U
Cancer Res; 2012 Apr; 72(8):2036-44. PubMed ID: 22367214
[TBL] [Abstract][Full Text] [Related]
23. Association between IL-4 -589C>T polymorphism and colorectal cancer risk.
Li Q; Wang Q; Xu X; Ren S; Wang L
Tumour Biol; 2014 Mar; 35(3):2675-9. PubMed ID: 24218339
[TBL] [Abstract][Full Text] [Related]
24. SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Huang Y; Wu W; Nie M; Li C; Wang L
Oncotarget; 2016 Nov; 7(46):75561-75570. PubMed ID: 28070019
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of adiponectin polymorphisms and colorectal cancer risk.
Ye C; Wang J; Tan S; Zhang J; Li M; Sun P
Int J Med Sci; 2013; 10(9):1113-20. PubMed ID: 23869187
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
[TBL] [Abstract][Full Text] [Related]
27. Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.
Wan D; Gu W; Xu G; Shen C; Ding D; Shen S; Wang S; Gong X; He S; Zhi Q
Clin Transl Oncol; 2014 Sep; 16(9):792-800. PubMed ID: 24399071
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-4 polymorphism and colorectal cancer risk: a meta analysis.
Li J; Sun C; Yuan Y; Liu L; Xiong G; Wu J
Mol Biol Rep; 2012 May; 39(5):5239-51. PubMed ID: 22170598
[TBL] [Abstract][Full Text] [Related]
29. TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population.
Mitroi AF; Leopa N; Dumitru E; Dumitru A; Tocia C; Popescu I; Mitroi A; Popescu RC
Medicine (Baltimore); 2023 Feb; 102(7):e33056. PubMed ID: 36800588
[TBL] [Abstract][Full Text] [Related]
30. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
[TBL] [Abstract][Full Text] [Related]
31. IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer.
Yin J; Zhang Z; Zheng H; Xu L
Oncotarget; 2017 Apr; 8(15):25107-25114. PubMed ID: 28212577
[TBL] [Abstract][Full Text] [Related]
32. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
34.
Fang D; Ye Y
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28706007
[TBL] [Abstract][Full Text] [Related]
35. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
Zhang LQ; Wang J; Shang JQ; Bai JL; Liu FY; Guan X; Zhou JN
Int J Colorectal Dis; 2011 Oct; 26(10):1249-55. PubMed ID: 21544737
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.
Zhao Z; Ba C; Wang W; Wang X; Xue R; Wu X
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1390-4. PubMed ID: 23005896
[TBL] [Abstract][Full Text] [Related]
38. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
[TBL] [Abstract][Full Text] [Related]
39. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.
Shi KQ; Lin Z; Li DW; Fang YX; Gao J; Deng ZJ; Chen L; Li GL; Wu JM; Tang KF
Onkologie; 2013; 36(10):560-5. PubMed ID: 24107909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
